The worsening impact of programmed cell death ligand 1 in ovarian clear cell carcinomas-Reference-Cited by-同舟云学术

The worsening impact of programmed cell death ligand 1 in ovarian clear cell carcinomas

Published:2022-05-04 Issue:6 Volume:306 Page:2133-2142
ISSN:1432-0711
Container-title:Archives of Gynecology and Obstetrics
language:en
Short-container-title:Arch Gynecol Obstet

Author:

Matsuura Hiroko,Miyamoto Morikazu^ORCID,Hada Taira,Ishibashi Hiroki,Iwahashi Hideki,Kakimoto Soichiro,Suzuki Rie,Ito Tsubasa,Suminokura Jin,Tsuda Hitoshi,Takano Masashi

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00404-022-06582-5.pdf

Reference36 articles.

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108. https://doi.org/10.3322/caac.21262

2. Trimbos JB, Vergote I, Bolis G, Vermorken JB, Mangioni C, Madronal C, Franchi M, Tateo S, Zanetta G, Scarfone G, Giurgea L, Timmers P, Coens C, Pecorelli S (2003) Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant Chemo Therapy in Ovarian neoplasm trial. J Natl Cancer Inst 95:113–125

3. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20:1248–1259. https://doi.org/10.1200/JCO.2002.20.5.1248

4. Takano M, Kikuchi Y, Yaegashi N, Kuzuya K, Ueki M, Tsuda H, Suzuki M, Kigawa J, Takeuchi S, Tsuda H, Moriya T, Sugiyama T (2006) Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging. Br J Cancer 94:1369–1374. https://doi.org/10.1038/sj.bjc.6603116

5. Ryu SY, Park SI, Nam BH, Kim I, Yoo CW, Nam JH, Lee KH, Cho CH, Kim JH, Park SY, Kim BG, Kang SB (2009) Prognostic significance of histological grade in clear-cell carcinoma of the ovary: a retrospective study of Korean Gynecologic Oncology Group. Ann Oncol 20:1032–1036. https://doi.org/10.1093/annonc/mdn764

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD-L1 expression in ovarian clear cell carcinoma using the 22C3 pharmDx assay;Diagnostic Pathology;2024-06-15

2. Application of PD-1/PD-L1 Inhibitors in Gynecological Tumors;World Journal of Cancer Research;2024

3. Exploring the cellular and molecular differences between ovarian clear cell carcinoma and high-grade serous carcinoma using single-cell RNA sequencing and GEO gene expression signatures;Cell & Bioscience;2023-07-31

4. EFEMP2 upregulates PD-L1 expression via EGFR/ERK1/2/c-Jun signaling to promote the invasion of ovarian cancer cells;Cellular & Molecular Biology Letters;2023-07-07

5. Immunohistochemical expression of PD-L1 and its correlation with microsatellite status in endometrial and ovarian clear cell carcinomas: a cross-sectional study;BMC Cancer;2022-12-29